Aljawharah Alrubayyi

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

NK-like and networked CD8 + T cell immunity mediates exceptional HIV control.

NK-like and networked CD8 + T cell immunity mediates exceptional HIV control.

Journal: bioRxiv : the preprint server for biology

Published: July 17, 2026

Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy.

Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Expansion of stemlike HIV-specific CD8+ T cells and limited viral epitope diversity characterize durable posttreatment control of HIV.

Expansion of stemlike HIV-specific CD8+ T cells and limited viral epitope diversity characterize durable posttreatment control of HIV.

Journal: Science translational medicine

Published: April 22, 2026

Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter].

Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter].

Journal: Infection and drug resistance

Published: March 14, 2026

Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory Approach.

Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory Approach.

Journal: Vaccines

Published: January 09, 2026

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Journal: medRxiv : the preprint server for health sciences

Published: April 16, 2025

Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Journal: Science translational medicine

Published: April 02, 2025

An early functional adaptive NK cell signature drives optimal CD8 + T-cell activation and predicts sustained HIV-1 viral control.

An early functional adaptive NK cell signature drives optimal CD8 + T-cell activation and predicts sustained HIV-1 viral control.

Journal: bioRxiv : the preprint server for biology

Published: April 01, 2025

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Journal: Gut

Published: April 01, 2025

Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes.

Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes.

Journal: Infectious disease clinics of North America

Published: March 15, 2025

Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy.

Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: June 27, 2024

HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses.

HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses.

Journal: Hepatology (Baltimore, Md.)

Published: November 10, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026